Low-dose captopril in the treatment of severe refractory hypertension associated with renal failure
Open Access
- 1 July 1982
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 58 (681) , 419-421
- https://doi.org/10.1136/pgmj.58.681.419
Abstract
Summary: Six patients with severe refractory hypertension and chronic renal failure were treated with a low dose of captopril (mean daily dose 75 mg) in combination with dietary sodium restriction, frusemide and either metoprolol, labetalol or prazosin. Sustained control of blood pressure was achieved in all six patients. Adverse effects noted were severe hyperkalaemia (2 patients), skin rashes (2 patients) and taste disturbance (1 patient).This publication has 12 references indexed in Scilit:
- Fatal bone-marrow suppression associated with captopril.BMJ, 1981
- CAPTOPRIL AND FRUSEMIDE IN SEVERE DRUG-RESISTANT HYPERTENSIONThe Lancet, 1980
- COMBINED TREATMENT OF SEVERE INTRACTABLE HYPERTENSION WITH CAPTOPRIL AND DIURETICThe Lancet, 1980
- Captopril-induced Changes in Prostaglandin ProductionJournal of Clinical Investigation, 1980
- IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRILThe Lancet, 1980
- Disposition of captopril in normal subjectsClinical Pharmacology & Therapeutics, 1980
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILUREThe Lancet, 1978
- Sensitization of the adrenal cortex to angiotensin II in sodium-deplete manCirculation Research, 1977
- Sensitization of the Adrenal Cortex to Angiotensin II in Sodium-Deplete ManCirculation Research, 1974